Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 77.72 USD -1.38% Market Closed
Market Cap: 3.9B USD
Have any thoughts about
Haemonetics Corp?
Write Note
Section:
 

Relative Value

The Relative Value of one HAE stock under the Base Case scenario is 135.13 USD. Compared to the current market price of 77.72 USD, Haemonetics Corp is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HAE Relative Value
Base Case
135.13 USD
Undervaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.9
P/S
P/S
Price to Sales
2.9
vs History
74
vs Industry
35
Median 3Y
3.4
Median 5Y
3.6
Industry
2.3
Forward
2.8
More Details
31.6
P/E
P/E
Price to Earnings
31.6
vs History
69
vs Industry
13
Median 3Y
36.8
Median 5Y
46.5
Industry
23
Forward
16.8
More Details
46.1
P/OCF
P/OCF
Price to OCF
46.1
vs History
4
vs Industry
16
Median 3Y
19.1
Median 5Y
26.9
Industry
14.3
More Details
7.5
P/FCFE
P/FCFE
Price to FCFE
7.5
vs History
77
vs Industry
17
Median 3Y
27.7
Median 5Y
27.7
Industry
20
More Details
4.5
P/B
P/B
Price to Book Value
4.5
vs History
41
vs Industry
18
Median 3Y
4.7
Median 5Y
5
Industry
2.2
More Details
3.6
EV/S
EV/S
Enterprise Value to Sales
3.6
vs History
52
vs Industry
30
Median 3Y
3.9
Median 5Y
4.1
Industry
2.4
Forward
3.4
More Details
6.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.6
vs History
60
vs Industry
30
Median 3Y
7.4
Median 5Y
7.8
Industry
5
More Details
14.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.9
vs History
80
vs Industry
21
Median 3Y
17.7
Median 5Y
18.7
Industry
12.9
Forward
11.3
More Details
22.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22.5
vs History
80
vs Industry
18
Median 3Y
27.6
Median 5Y
32
Industry
17.4
Forward
14.5
More Details
56.9
EV/OCF
EV/OCF
Enterprise Value to OCF
56.9
vs History
0
vs Industry
14
Median 3Y
21.7
Median 5Y
29.2
Industry
14
More Details
155.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
155.4
vs History
0
vs Industry
10
Median 3Y
42.4
Median 5Y
47.9
Industry
18.2
More Details
2.2
EV/IC
EV/IC
Enterprise Value to IC
2.2
vs History
65
vs Industry
30
Median 3Y
2.6
Median 5Y
2.8
Industry
1.9
More Details

Multiples Across Competitors

HAE Competitors Multiples
Haemonetics Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Haemonetics Corp
NYSE:HAE
3.9B USD 2.9 31.6 14.9 22.5
JP
Hoya Corp
TSE:7741
7T JPY 8.6 35.9 23.7 28.5
CH
Alcon AG
SIX:ALC
38.2B CHF 4.3 36.2 17.8 34.4
DK
Coloplast A/S
CSE:COLO B
177.1B DKK 6.6 35.1 22.6 26.6
US
Align Technology Inc
NASDAQ:ALGN
16.3B USD 4.1 36.8 18.6 22.4
KR
HLB Inc
KOSDAQ:028300
10.3T KRW 198.6 -55.5 -85.5 -80.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51B CNY 11.5 27.6 23.9 23.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.7B USD 4.5 15.8 10.9 12.4
CA
Bausch + Lomb Corp
NYSE:BLCO
6.3B USD 1.3 -17.1 16.6 55.6
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.6 37.1 264.5 462
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.2 46.5 23.2 38.1
P/E Multiple
Earnings Growth PEG
US
Haemonetics Corp
NYSE:HAE
Average P/E: 33.6
31.6
38%
0.8
JP
Hoya Corp
TSE:7741
35.9
15%
2.4
CH
Alcon AG
SIX:ALC
36.2
27%
1.3
DK
Coloplast A/S
CSE:COLO B
35.1
15%
2.3
US
Align Technology Inc
NASDAQ:ALGN
36.8
26%
1.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -55.5 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.6
24%
1.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
15.8
19%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.1 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
37.1
46%
0.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
46.5
37%
1.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Haemonetics Corp
NYSE:HAE
Average EV/EBITDA: 43.7
14.9
15%
1
JP
Hoya Corp
TSE:7741
23.7
15%
1.6
CH
Alcon AG
SIX:ALC
17.8
10%
1.8
DK
Coloplast A/S
CSE:COLO B
22.6
11%
2.1
US
Align Technology Inc
NASDAQ:ALGN
18.6
15%
1.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -85.5 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.9
27%
0.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.9
11%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.6
22%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
264.5
12%
22
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.2
22%
1.1

See Also

Summary
HAE intrinsic value, competitors valuation, and company profile.
DCF Valuation
HAE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HAE stock valuation using valuation multiples.
Wall Street Estimates
HAE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HAE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 215,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.